Protein-Kinase-C inhibitors and gemfibrozil prevent the enhancing effect of very low density lipoproteins on the biosynthesis of plasminogen activator inhibitor type 1 by HepG2 cells by E. Tremoli et al.
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UKYSTA! STRUCTL]RE OF A CLEA}ED VARIANT OF HUMAN
:Lf ryOgry ACTTVATOR INHIBTTOR-I. Kaîhteen Aenseerts. HendrikL uè tsondt. camlet De RaElqr an-d paul J Declerckr Labontcry fcr
|.n"tyu.t Chcmirry and Mcdicinal physicochemistryii .Ldborarory for
Pharmaceutical Biology and phytopharmacology, Facuity of pharmaccurical
Scimccs, K.U.Lavcn, Belgium.
Thc scrinc protcinase inhibiror (serpin) plasminogcn activator inhibiror_l (pAI-l) can odopt threc difrcrcnt conformadons: acriic, latcnr anJ substratc, each
f_,ljlT:1.:, fungrional propcnies. To chracterize thc srrusîuml requircmcnrsrorthe contormanonal flexibility ofpAJ_l wc havc solved thc X_ray structure of
:-"]*1"9 (sr Pl-Pl'), humarl.subst-rarc pAJ_l mutant (Ala_rpro at positionPl2; Audenaen er al., J. Biol. Chan.269,19559, t99a) roaiT i resolurion.
Thc thrce dimensionaj structure rwealcd lhrec main ieatures- Firstly, the N_rcmind sidc (Pl6.pl) of thc rcacrivc siîe loop was complcteley inscned into p-
sheet d yielding a p-strand s4A Secondiy, -a in'contrusi to rle X-raystructure- of larcnr pAJ-l Gr{ottglgn a a.1., Naturc 3SS. 270, t992), a new p-strand stC was formed from p6' to_ p_10,_ (Itc Zsî-/ug S!à1' Thirdly, the
11esen1g 
of a rclativcly imponanr.fluibility in two loopsilose ío slC floopl-connecring s4C wirh s3C and ..loopZ- comeaing s:e w;if-frq could bededuced. Whcreas in the ilrrenî tructure thc sma.llest distalce (of thcbackbonc aroms) berween rhese rwo loops is only ?À, ìt l, ìi,l i"l"r""t par- rBased on the 3D-struaure of the intact md claved sefin'orarUumin, ir ;commonly aftepted that a substrateJike serpin does not have tòe ability offorming p-strand s4a However, our data clealy showed that lhe subsîrate
behaviour ofthis PAI-I varimr is associated *fti, rte genention ofa p_strand*4.. fh" evidencc for the easy movement of the loopJclose to slC provides a .possible explaation for the lability ofactive pAJ-l: iuring rheìransition oflhe
residues P6 -Pl I' tom rhe p-stnnd sl C (presumably also lresent in acuve pA-I-l) to the loop in the larent onfomauo4 the gap between loopl ad loopZ isenlarged due to a stdical hindrance (Coulomblc'md ,- a", fi-, repuision)
between P6'-Pl I' and loopl.
In conclusiorq the X-ny nructure of îhe cleaved vuiant of huma pAI_lprovids new data funher illustmring rhe uniqueness of pÀ-f *;*i" the serpinsuperfarnily.
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TYPE I PLASMINOGEN ACTMTOR INHIBITOR cgNE E)CpRESslor\, ,.
INCREASED IN PROLIFERATING ENDOTHELIAL CELLS. Irene M-; ;:_ll
Ccrtraud. Lang',..Wolfgang Farbc/, Kenncth Moscr^, -a R yroìa-ilffi^.
-uruv€rstty oî vienna, Ausrri4 "Univcrsiry of Califomi4 San Dicgo, Califo-;.
U.S.A.; and 'Thc Scripps Rescarch lnsúture, La Jolia, Califomia, U.$.,q. 
--"*
Althougi abnormal th.rombus formation plays a kcy rolc in a varietv 
^,cardiovascular disorders, Iinle information is availablc on the local rncci,r"i.i.
tlat $abilizc and furthcr fibrin deposition in various parhologica.l .onaitior,, f1icurrenl mar*cr for a pretkombotic statc is the plasma lcvcl of typc t plasmlno"_
actrvator inhibitor (PAJ-I), ùc rnajor inhibitor of tissuc-typc pt*r,in"i_
activator. To detcrminc whcther îhe abnormal production of this nU.inoìi",'-
hhibitor is involvcd in boù acutc and chronic vascular rhrombus f"*"ii;;:îì
have anaiyzcd specimens hanested from paticnts wiù acutc puimonary cmbolj ara
llY,"-__y|:tg"i"g pulmonary rhromboendanerccromy fór .bil;trtrombocîbolic pulmonary hypcnension (CTEplI). For comparisorl putrnoia*
ffienes trom orge donors werc hflcled md proccssed in a simiiar fasfuon. l"sirr hybridization and i.rnmunohistochcmica.l zrulysis of u.ut. pul.onu.y .iUoi
rcvealed inlensc PAJ-I immuorsctivity aad -nNa s;gna "à"nn.a ú ilri**endothelial cclls @Cs) ir îhe closc viJiniry of rhc cenlal fr.sh fib.in_plai.t
thrombus. These ECs appeared to iavadc into the tfuombu from îhe ma:gi6
thus forming new lumina wirhin the clor Moreover, higl levels of pAJ_ f -io*land rrRNA vere derccted in ECs lining rcd, fibrin-rich *"omUl as *ltt'i
neovascular strucntrs within orgmized yellowish-white thrombocmboli froi
patrents with CTEPH. To clai! whethcr high pAJ-l gcnc exprcssion wirhin ECs
in pulmonary ancries of patients with rcrne md chronic pulmonary thromboembol,
was specific, pulmonary lhromboemboli derived from a cminc model of acls
lùoTq embolism werc mlfad. Simila intcme pAl-l imunoreactivity ua
detected in ECs lining 7 and 30-day-old caine thromboemboli. positj".
immunoreactiviry of these ECs with proiiferating nuciear cell andgeo dcmon*-arC
that thc ECs lining fibrin-plareler thrcmbi were proliferating cells rhar wg1
actively involved in the early organization proccss of îhc cjots. It is concludcc
tlat ilcreased PAI-1 expression wirhin orgarizing vascular tlrombi may be reiarcc
to the prolifcrative srate of pulmonary arterial ECs.
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PROTEIN KINASE C INHIBITORS AND GEMFIBROZIL PREVENT THE
ENHANCING EFFECT OF VERY LOW DENSITY r.ÉóPNOrEirgS Or.r
THE BIOSYNTHESIS OF PLASMINOGEN ACTIVATOR II,IUIETOR TYPE1 BY HepG2 CELLS. Elena Tremoli. Cristina Banfì. Luioi.Sironi. úauro
Pharmacological Sciences, University of VGn, ffafi,. 
-
Triglyceride-rich llpoproteins (VLDL) have been previousry snown to
9llangg the biosynthesis oi ptasminogen activator inhibitor type 1 (pAI-1) by HepG2 cells. This stuày was u;dertaken to assess wheîher the
effect of VLDL on PAI-I antigeh and mRNA induction could be by protein
.li11-.? 9_ 
(PKC) 
.signating parlwly; To this end confluenl Hepbà ceitswere trrst Incubated for 16 h with VLDL isolated from normal dbnors, at
the_ 100 gg/ml concentralion with of without inhibiîors of pKC. At the end
of .incubaîion PAI-.I antigen released in the conditioned medium wasdetermined by ELISA and pAl-1 mRNA expression was assesseo DyNothem_analysis. Exposure of HepG2 cells io .100 uq/mt VLDL resuiteóin a îwofold increase in pAl-1 antigen release and-total pAl_1 mRNA
expression. H7 (50 ptvl) and sphingosine (3-5 pM) almost compleleiy
prg_v9nte_d (ì 800/4 the eflèct of VLDL on pAl_l antigen reiease and lotal
PAI-1 mRNA accumulation. ln addition down regulatÉn oi pKC, obtained
by preincubation of FjepG2 cells with pMA (:10ó nM) lor 24h, prevenîed
the effect of VLDL on pAl-1 biosynrhesis. Estabtish;d that thé eflect of
VLDL..on PAI-1 bisosynlhesis was mediated by activation of pKC
signaling pathway we evaluated whether f ibiic acio deflvatives
influenced PAI-1 biosynthesis in unstimulaîed HepG2 cells and in cells
exposed to VLDL. ln unstimllated HepG2 cells, Gemfibrozil (0.1_0.75
mM) significantly reduced pAl-1 antigen release (_g5 % at the O.7S mMconcentratlon) and mRNA expression, whereas BezaftDrate at thehig-hesl.concentration used (1 mM) reduced pAl-.1 antigen retease Dy
20"/", with no eff€ct on pAl-1 mFìNÀ expression. In VLDL treaied ceils,only Gemfibrozil, at the 0.7S mM concéntration, .n"^r.Lo (_50%) thebiosynthesis ot PAt-1 as induced by VLDL trOO frg/;li.-iiis conctudedthal VLDL enhance pAl-1 bio..synrhlsis rhrough ;;ú;i;.; of pKC andthat Gemfibrozil, bul not Bezart'rate, anenuates pAl-1 inducîton In thesecells.
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THE CLEAVAGE AND INACTIVATION OF PLASMINOGEN
ACTIVATOR |NHIBtTOR TYPE 1 By NEUTFOPHTL ELASTASE: THE
EVALUATION OF ITS PHYSIOLOGICAL RELEVANCE IN
FIBRINOLYSIS. Tetsumei Urano. Kai Wu. Havato lhàra yurikc
Iakada and Akikazu Takada. Dept. of physiology, Hamamarsu
University School of Medicine, Hamamatsu, Jaàa;
The eifect of the proteolytic cleavage of plasminogen
activator inhibitor type 1 (pAl-1) by human neutropnil
elastase (HNE) _on fibrinolysis was investigated. HNE cleavec
active recombinant prokaryotic pAl-1 (rppAl-1) resulting in
the formation of lovù molecular weight forms of rppAl_1 as
previousty reporled (Levin & Sanreil, J. Ceil Biol. 1987). The
latent form of rpPAl-1 was resistant to HNE. NH2-terminai
Sequence analysis indicated that the cleavaOe site was
Val355-Se1356 (P4-P3). The fad that the straìned toop oÍ
the latent form of PAI-1 is buried inside the molecule nrosl
likely accounts for its resistance lo HNE. Alter the cleavage
by HNE, active rpPAl- 1 lost its specrfic activity toward
plasminogen activators. The cleavage was under both enzyme
concentraîion and lrme dependent, and the almost complele
inactivation of rpPAl-1 (2.9 pM) activìty was obtained by a
HNE (83 nM) trealment for 30 min. at 37"C. The effect ol
PAI-1 cieavage by HNE on t-PA induced clot lysis was studied
in a purified system. Clot lysis time without rppAl-1 was
20.0 t 5.0 min., and was prolonged to 86.7 t 2.9 min. by BB nM
of rpPAl-1. lt was shortened when HNE (from 0.6 nM to 80
nM) was added and returned to the value obtained without
rpPAl-1 when 80 nM of HNE'present (20.0 t 5.8 min.). In the
absence of PAI-1, however, the elastase did not anh"naa .lol
lysis at all. The cleavage and inactívation of pAl-i bv HNE
was shown to be a novel pathway to ennance flbrinolysii.
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